Impinj Insider Sold Shares Worth $1,471,303, According to a Recent SEC Filing-February 2024-www.financetom.com

Impinj Insider Sold Shares Worth $1,471,303, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Impinj Insider Sold Shares Worth $1,471,303, According to a Recent SEC Filing

Jun 12, 2024 1:01 AM

03:31 AM EDT, 06/12/2024 (MT Newswires) -- Chris Diorio, Director, Chief Executive Officer, on June 10, 2024, sold 10,000 shares in Impinj ( PI ) for $1,471,303. Following the Form 4 filing with the SEC, Diorio has control over a total of 838,724 shares of the company, with 286,230 shares held directly and 552,494 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1114995/000141588924016431/xslF345X03/form4-06112024_100636.xml

Previous page： Stellantis to Collaborate with France's CEA to Build Next-Generation Battery Cells for EVs Next page： SeaStar Medical Says US FDA Agrees to Final Labeling for Quelimmune

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Stellantis to Collaborate with France's CEA to Build Next-Generation Battery Cells for EVs

Jul 3, 2024

09:16 AM EDT, 07/03/2024 (MT Newswires) -- Stellantis NV ( STLA ) said Wednesday it will collaborate with the French research organization CEA over the next five years to design next-generation battery cells for electric vehicles. The joint program includes designing advanced technology cells that provide a higher performance, longer lifespan and lower carbon footprint, Stellantis ( STLA ) said....

SeaStar Medical Says US FDA Agrees to Final Labeling for Quelimmune

Jul 3, 2024

09:15 AM EDT, 07/03/2024 (MT Newswires) -- SeaStar Medical Holding ( ICU ) said Wednesday that the US Food and Drug Administration has agreed to the final labeling for its Quelimmune device to treat children with acute kidney injury and sepsis or septic condition requiring kidney replacement therapy. The commercial-stage medical technology company said the final labeling paves the way...

Quest Diagnostics expands into Canada with nearly $1 bln LifeLabs deal

Jul 3, 2024

July 3 (Reuters) - Quest Diagnostics ( DGX ) said on Wednesday it would acquire Canada-based LifeLabs from pension plan owner OMERS for about C$1.35 billion, or about $985 million, including net debt. LifeLabs, which provides community laboratory tests, would retain its brand, Canadian headquarters and management after the acquisition is closed. The U.S. laboratory operator will acquire 100% of...

Lifeist Wellness Names Andrea Judge As CEO of Mikra Cellular Sciences

Jul 3, 2024

09:18 AM EDT, 07/03/2024 (MT Newswires) -- Lifeist Wellness ( LFSWF ) , a health-tech company trading near 52 week lows, on Wednesday named Andrea Judge as vice president of operations at Lifeist and chief executive officer of Mikra Cellular Sciences, effective immediatly. Judge, who has experience in sales, marketing, and executive management, began her professional career in marketing at...